| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
786,383 |
|
|
Indirect Shares
|
362,461 |
|
|
| Direct
Value |
$788,702,830 |
|
|
|
Indirect Value
|
$363,530,260 |
|
|
| Total
Shares |
1,148,844 |
|
|
| Total
Value |
$1,152,233,090 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-16 |
786,383 |
2024-05-16 |
362,461 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-16 |
4 |
AS |
$24.40 |
$758,006 |
D/D |
(30,883) |
67,496 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-03-26 |
4 |
AS |
$120.21 |
$3,985,850 |
D/D |
(33,150) |
866,206 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-05-01 |
4 |
AS |
$133.95 |
$4,471,669 |
D/D |
(33,165) |
833,041 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-04-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
36,296 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres Regen Res Labs |
• • – |
2012-12-14 |
4 |
D |
$179.13 |
$6,876,980 |
D/D |
(38,391) |
1,294,650 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2011-12-14 |
4 |
D |
$51.18 |
$1,971,249 |
D/D |
(38,516) |
860,754 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Pres Regeneron Labs |
• • – |
2013-12-16 |
4 |
D |
$272.73 |
$11,720,299 |
D/D |
(42,974) |
1,063,638 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-11-02 |
4 |
AS |
$561.75 |
$24,778,125 |
D/D |
(43,348) |
543,348 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2015-11-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
43,348 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2015-11-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
43,348 |
612,936 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-12-02 |
4 |
AS |
$542.72 |
$23,799,539 |
D/D |
(43,348) |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2008-12-16 |
4 |
D |
$16.42 |
$785,993 |
D/D |
(47,868) |
588,235 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-08-16 |
4 |
AS |
$625.25 |
$30,781,138 |
D/D |
(49,227) |
887,483 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-09-17 |
4 |
S |
$20.25 |
$1,013,190 |
D/D |
(49,600) |
81,051 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-08-05 |
4 |
AS |
$600.06 |
$30,003,000 |
D/D |
(50,000) |
937,483 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-05-15 |
4 |
AS |
$965.69 |
$48,793,727 |
D/D |
(50,000) |
836,383 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-05-16 |
4 |
AS |
$967.40 |
$48,636,545 |
D/D |
(50,000) |
786,383 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-09-17 |
4 |
D |
$20.95 |
$1,051,669 |
D/D |
(50,199) |
130,651 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres Regen Res Labs |
• • – |
2012-12-19 |
4 |
OE |
$9.49 |
$699,978 |
D/D |
50,846 |
1,117,330 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-07-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
57,465 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-13 |
4 |
D |
$24.60 |
$1,455,361 |
D/D |
(59,161) |
98,379 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-02-15 |
4 |
D |
$109.29 |
$7,324,288 |
D/D |
(67,017) |
899,356 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO & Pres Regn Res Labs |
• • – |
2009-12-03 |
4 |
D |
$19.29 |
$1,309,019 |
D/D |
(67,860) |
620,375 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-08-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
75,036 |
328,352 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-08-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
75,036 |
0 |
0 |
- |
|
145 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
